Polymorphisms in XPD (Asp312Asn and Lys751Gln) genes, sunburn and arsenic-related skin lesions

Carcinogenesis

Volumn 28, Issue 8, 2007, Pages 1697-1702

  McCarty, Kathleen M ^a,b   Smith, Thomas J ^b   Zhou, Wei ^b   Gonzalez, Ernesto ^c   Quamruzzaman, Quazzi ^d   Rahman, Mahmuder ^d   Mahiuddin, Golam ^d   Ryan, Louise ^b   Su, Li ^b   Christiani, David C ^b  

^a YALE UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b HARVARD SCHOOL OF PUBLIC HEALTH   (United States)

^c MASSACHUSETTS GENERAL HOSPITAL   (United States)

^d Dhaka Community Hospital   (Bangladesh)

Author keywords

[No Author keywords available]

Indexed keywords

ARSENIC; XERODERMA PIGMENTOSUM GROUP D PROTEIN;

ADULT; ARSENIC POISONING; ARTICLE; BANGLADESH; CANCER RISK; CHEMICAL CARCINOGENESIS; CONTROLLED STUDY; DNA REPAIR; FEMALE; GENETIC ASSOCIATION; GENETIC SUSCEPTIBILITY; GENETIC VARIABILITY; GENOTYPE ENVIRONMENT INTERACTION; HETEROZYGOSITY; HOMOZYGOSITY; HUMAN; KERATOSIS; MAJOR CLINICAL STUDY; MALE; MELANOSIS; POPULATION BASED CASE CONTROL STUDY; POPULATION EXPOSURE; PRIORITY JOURNAL; SINGLE NUCLEOTIDE POLYMORPHISM; SKIN CARCINOGENESIS; SKIN DEFECT; SKIN DISEASE; SUN EXPOSURE; SUNBURN;

ADULT; AMINO ACID SUBSTITUTION; ARSENIC; ASPARAGINE; ASPARTIC ACID; CASE-CONTROL STUDIES; FEMALE; GENETIC PREDISPOSITION TO DISEASE; GLUTAMINE; HUMANS; LYSINE; MALE; POLYMORPHISM, SINGLE NUCLEOTIDE; SKIN DISEASES; SUNBURN; WATER SUPPLY; XERODERMA PIGMENTOSUM GROUP D PROTEIN;

EID: 34548070426     PISSN: 01433334     EISSN: 14602180     Source Type: Journal    
DOI: 10.1093/carcin/bgm099     Document Type: Article

References (52)

1. Ahsan, H. et al. (2003) DNA repair gene XPD and susceptibility to arsenic-induced hyperkeratosis. Toxicol. Lett., 143, 123-131.
2. Kitchin,K.T. (2001) Recent advances in arsenic carcinogenesis: Modes of action, animal model systems, and methylated arsenic metabolites. Toxicol. Appl. Pharmacol., 172, 249-261.
3. National Research Council (1999) Arsenic in drinking Water. In Subcommittee on Arsenic in Drinking Water, C.o.T., Board on Environmental Studies and Toxicology Commmon on Life Sciences, National Research Council. (eds). National Academy Press Washington, DC. pp.104.
4. Alain,G. et al. (1993) Chronic arsenic toxicity. Int. J. Dermatol, 32, 899-901.
5. Rossman,T.G. (1981) Enhancement of UV-mutagenesis by low concentrations of arsenite in E.coli. Mutat. Res., 91, 207-211.
6. Rossman, T.G. et al. (2001) Arsenite is a cocarcinogen with solar ultraviolet radiation for mouse skin: An animal model for arsenic carcinogenesis. Toxicol. Appl. Pharmacol., 176, 64-71.
7. Mudipalli, A. et al. (2005) The effect of arsenicals on ultraviolet-radiation-induced growth arrest and related signaling events in human keratinocytes. Int. J. Oncol., 27, 769-778.
8. Rossman,T.G. et al. (2002) Arsenite cocarcinogenesis: An animal model derived from genetic toxicology studies. Environ. Health Perspect., 110, 749-752.
9. Angelina,S.A. et al. (2003) Decreased DNA repair gene expression among individuals exposed to arsenic in United States drinking water, 104 263-268.
10. Germolec,D.R. et al. (1998) Arsenic enhancement of skin neoplasia by chronic stimulation of growth factors. Am. J. Pathol., 153 1775-1785.
11. Burns,F.J. et al. (2004) Arsenic-induced enhancement of ultraviolet radiation carcinogenesis in mouse skin: A dose-response study. Environ. Health Perspect., 112, 599-603.
12. Chen,P.H. et al. (2005) Effects of arsenic and UVB on normal human cultured keratinocytes: Impact on apoptosis and implication on photocarcinogenesis. Chem. Res. Toxicol., 18, 139-144.
13. Okui,T. et al. (1986) Inhibition of human excision DNA repair by inorganic arsenic and the co-mutagenic effect in V79 Chinese hamster cells. Mutat. Res., 172, 69-76.
14. Li,J.H. et al. (1991) Comutagenesis of sodium arsenite with ultraviolet radiation in Chinese hamster V79 cells. Biol. Met., 4, 197-200.
15. Yamanaka,K. et al. (2000) The role of orally administered dimethylarsinic acid, a main metabolite of inorganic arsenics, in the promotion and progression of UVB-induced skin tumorigenesis in hairless mice. Cancer Lett., 152, 79-85.
16. Ramos, J. et al. (2004) UV dose determines key characteristics of nonmelanoma skin cancer. Cancer Epidemiol. Biomarkers Prev., 13 2006-2011.
17. Maloney,M. (1996) Arsenic in dermatology. Dermatol, Surg., 22 301-304.
18. Kraemer, K.H. et al. (1994) The role of sunlight and DNA repair in melanoma and nonmelanoma skin cancer. The xeroderma pigmentosum paradigm. Arch. Dermatol., 130, 1018-1021.
19. Lehmann,A.R. (2001) The xeroderma pigmentosum group D (XPD) gene: One gene, two functions, three diseases, Genes Div. 2001, 15(1): 15-23.
20. Sancar,A. (1995) DNA repair in humans. Annu. Rev. Genet., 29 69-105.
21. Benhamou,S. et al. (2005) ERCC2/XPD Gene polymorphisms and lung cancer: A HuGE review, AJE. 2005, 161(1):1-14.
22. Danaee,H. et al. (2004) Low dose exposure to sodium arsenite synergistically interacts with UV radiation to induce mutations and alter DNA repair in human cells. Mutagenesis, 19 143-148.
23. Shen,M.R. et al. (1998) Nonconservative amino acid substitution variants exist at polymorphic frequency in DNA repair genes in healthy humans. Cancer Res., 58, 604-608.
24. Hemminki,K. et al. (2001) XPD exon 10 and 23 polymorphisms and DNA repair in human skin in situ. Carcinogenesis, 22, 1185-1188.
25. Lunn,R.M. et al. (2000) XPD polymorphisms: Effects on DNA repair proficiency. Carcinogenesis, 21, 551-555.
26. Au,W.W. et al. (2003) Functional characterization of polymorphisms in DNA repair genes using cytogenetic challenge assays. Environ. Health Perspect., 111, 1843-1850.
27. Manuguerra,M. et al. (2006) XRCC3 and XPD/ERCC2 Single nucleotide polymorphisms and the risk of cancer: A HuGE review. Am. J. Epidemiol., 164, 297-302.
28. Banerjee,M. et al. (2006) Polymorphism in the ERCC2 codon 751 is associated with arsenic-induced premalignant hyperkeratosis and significant chromosome aberrations. Carcinogenesis, 28, 672-676.
29. McCarty,K.M. et al. (2006) The impact of diet and betel nut use on skin lesions associated with drinking-water arsenic in Pabus, Bangladesh. Environ. Health Perspect., 114, 334-340.
30. Joya,S.F.et al. (2006) One solution to the arsenic problem: A return to surface (improved dug) wells. J. Health Popul. Nutr., 24, 363-375.
31. McCarty,K.M. et al. (2007) Arsenic methylation, GSTT1, GSTM1, GSTP1 polymorphisms and Skin Lesions. Environ. Health Perspect., 115, 341-345.
32. McCarty,K.M. et al. (2007) GSTT1, GSTM1, GSTP1 Polymorphisms, and arsenic related skin lesions. Environmental Health, 6, 5.
33. U.S. Environmental and Protection Agency. (1994) Method 200.8, Determination of Trace Elements in Waters and Wastes by Inductively Coupled Plasma Mass Spectrometry, Cincinnati, OH.
34. Duell,E.J. et al. (2000) Polymorphisms in the DNA repair genes XRCC1 and ERCC2 and biomarkers of DNA damage in human blood mononuclear cells. Carcinogenesis, 21, 965-971.
35. Zhou,W. et al. (2002) Gene-environment interaction for the-ERCC2 polymorphism and cumulative cigarette smoking exposure in lung cancer Cancer Res., 62, 1377-1381.
36. Rothman,K.J. et al. (1998) Chapter 10 matching. Modern Epidemiology Lippincott, Williams & Wilkins, New York.
37. Rothman,K.J. et al. (1998) Chapter 21 introduction to regression modeling. Modern Epidemiology: Lippincott, William & Wilkins, New York.
38. Hosmer,D.W. et al. (1989) Applied Logistic Regression. John Wiley & Sons, New York.
39. Vogel,U. et al. (2001) Polymorphisms of the DNA repair gene XPD: correlations with risk of basal cell carcinoma revisited. Carcinogenesis, 22, 899-904.
40. Dybdahl,M. et al. (1999) Polymorphisms in the DNA repair gene XPD: correlations with risk and age at onset of basal cell carcinoma. Cancer Epidemiol. Biomarkers Prev., 8, 77-81.
41. Han,J. et al. (2005) Gentic variation in XPD, sun exposure and risk of skin cancer. Cancer Epidemiol. Biomarkers Prev., 14, 1539-1544.
42. Qiao,Y. et al. (2000) Modulation of repair of ultraviolet damage in the host-cell reactivation assay by polymorphic XPC and XPD/ERCC2 genotypes. Carcinogenesis, 23, 295-299.
43. Terry,M.B. et al. (2004) Polymorphism in the DNA repair gene XPD, polycyclic aromatic hydrocarbon-DNA adducts, cigarette smoking, and breast cancer risk. Cancer Epidemiol. Biomarkers Prev., 13, 2053-2058.
44. Justenhoven,C. et al. (2004) ERCC2 Genotypes and a corresponding haplotype are linked with breast cancer risk in a German population. Cancer Epidemiol. Biomarkers Prev., 13, 2059-2064.
45. Clarkson,S.G. et al. (2005) Polymorphisms in the human XPD (ERCC2) gene, DNA repair capacity and cancer susceptibility: An appraisal. DNA Repair, 4, 1068-1074.
46. Seker,H. et al. (2001) Functional significance of XPD polymorphic variants: Attenuated apoptosis in human lymphoblastoid cells with the XPD 312 Asp/Asp genotype. Cancer Res., 61, 7430-7434.
47. Ramos,J. et al. (2004) UV dose determines key characteristics of nonmelanoma skin cancer CFBP. 2004, 13(12):20061-2011.
48. Chen,Y. et al. (2006) Modification of risk of arsenic-induced skin lesions by sunlight exposure, smoking, and occupational exposures in Bangladesh. Epidemiology, 17, 459-467.
49. Han,J. et al. (2004) Genetic variation in XRCC1, sun exposure, and risk of skin cancer. Br. J. Cancer, 91, 1604-1609.
50. Nelson,H.H. et al. (2002) The XRCC1 Arg399Gln polymorphism, sunburn, and non melanoma skin cancer: Evidence of gene-environment interaction. Cancer Res., 62, 152-155.
51. Clouser,M.C. et al. (2006) Risk group, skin lesion history, and sun sensitivity reliability in squamous cell skin cancer progression. Cancer Epidemiol. Biomarkers Prev., 15, 2292-2297.
52. Cheng,Z. et al. (2005) Limited temporal variability of arsenic concentrations in 20 wells monitored for 3 years in Araihazar, Bangladesh. Environ. Sci. Technol., 39, 4759-4766.